Understanding how to improve organ transplant success by regulating immune responses

Studying and regulating trained immunity in mouse transplant models

['FUNDING_P01'] · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · NIH-11064095

This study is looking at ways to help the immune system accept transplanted organs without needing lifelong medication to suppress it, which could make organ transplants safer and easier for patients.

Quick facts

Phase['FUNDING_P01']
Study typeNih_funding
SexAll
SponsorICAHN SCHOOL OF MEDICINE AT MOUNT SINAI (nih funded)
Locations1 site (NEW YORK, UNITED STATES)
Trial IDNIH-11064095 on ClinicalTrials.gov

What this research studies

This research investigates how the immune system can be trained to accept transplanted organs without the need for long-term immunosuppressive therapy. By studying mouse models, the researchers aim to identify mechanisms that lead to better tolerance of transplanted organs, particularly focusing on differences between various organ types. The approach involves examining how certain organs can promote tolerance in others and how trained immunity affects the rejection of transplants. This could lead to new therapies that enhance graft survival and reduce side effects for patients.

Who could benefit from this research

Good fit: Ideal candidates for this research are individuals who have received or are considering organ transplants, particularly for organs like the heart or lungs.

Not a fit: Patients who are not candidates for organ transplantation or those with conditions unrelated to transplant rejection may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to improved organ transplant outcomes, allowing patients to live without the burdens of chronic immunosuppression.

How similar studies have performed: Previous research has shown promise in understanding organ tolerance, but this specific approach focusing on trained immunity in transplantation is relatively novel.

Where this research is happening

NEW YORK, UNITED STATES

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.

View on NIH RePORTER →

Last reviewed 2026-05-15 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.